ANALYST INTERVIEW: EUROPEAN BIOTECHNOLOGY COMPANIES: KARL KEEGAN - UBS WARBURG.(NAE904) EUROPEAN BIOTECHNOLOGY COMPANIES: KARL KEEGAN - UBS UBS Union Bank of Switzerland UBS United Bible Societies UBS United Blood Services UBS United Buying Service UBS Used Bookstore UBS University Business Services UBS Universal Building Society (UK) UBS Ulaanbaatar Broadcasting System WARBURG. Reviews the performance of the industry, and examines recent changes that have impacted companies in that sector. Topics discussed include competition, mergers and acquisitions, and the development of customer demand; and a number of companies are identified that are considered well positioned to succeed in the current market. Sector: Biotechnology. Published date 10/12/01. Tickers featured: CATG CATG Council of Athabascan Tribal Governments (Fort Yukon, Alaska) CATG Canadian Association of Teachers of German CATG Computer Aided Test Generator CATG Capital Assets Task Group , CLL CLL abbr. chronic lymphocytic leukemia CLL, n.pr See leukemia, chronic lymphocytic. CLL 1. Chronic lymphocytic leukemia 2. Cholesterol-lowering lipid , CRXL, LEON, OGSI OGSI Open Grid Services Infrastructure (grid computing) OGSI Online Game Services Inc. , SHPGY, SRA. Complete text approximately 3000 words. Document # NAE904. ANALYST INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com. *** |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion